Cargando…
Prevalence of extended treatment in pulmonary tuberculosis patients receiving first-line therapy and its association with recurrent tuberculosis in Beijing, China
BACKGROUND: In China, it is known that extended treatment is given to patients with pulmonary TB after they have successfully completed 6 months of first-line treatment. This practice is not officially reported to the National Tuberculosis Control Programme, so there are no data on its prevalence, i...
Autores principales: | Xia, YinYin, Goel, Sonu, Harries, Anthony D., Zhang, ZhiGuo, Gao, TieJie, Wang, LiXia, Cheng, ShiMing, Lin, Yan, Du, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059280/ https://www.ncbi.nlm.nih.gov/pubmed/24864048 http://dx.doi.org/10.1093/trstmh/tru066 |
Ejemplares similares
-
Diagnostic Value of Symptom Screening for Pulmonary Tuberculosis in China
por: Cheng, Jun, et al.
Publicado: (2015) -
Relapse Versus Reinfection of Recurrent Tuberculosis Patients in a National Tuberculosis Specialized Hospital in Beijing, China
por: Zong, Zhaojing, et al.
Publicado: (2018) -
Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison
por: Sun, Yong-Jiang, et al.
Publicado: (2006) -
Mycobacterium tuberculosis Beijing Genotype(1)
por: Lillebaek, Troels, et al.
Publicado: (2003) -
Mycobacterium tuberculosis Beijing Genotype, the Netherlands
por: Borgdorff, Martien W., et al.
Publicado: (2003)